Tango Therapeutics, Inc. (TNGX)

Number of records: 50
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
18-Nov-24 7:20 PM
View: 
Rothenberg MacE
Director
Tango Therapeutics, Inc. (TNGX) 18-Nov-24Purchase 10,000$3.78$37,800.0047%
21.25K to 31.25K
18-Nov-24 7:20 PM
View: 
Rothenberg MacE
Director
Tango Therapeutics, Inc. (TNGX) 14-Nov-24Private Purchase 10,000$3.62$36,200.0089%
11.25K to 21.25K
17-Sep-24 4:48 PM
View: 
Third Rock Ventures Iv, L.P.
10% Owner
Tango Therapeutics, Inc. (TNGX) 13-Sep-24Market Sale 67,400$10.53$709,756.00(< 1%)
16.93M to 16.86M
3%
09-Sep-24 7:19 PM
View: 
Third Rock Ventures Iv, L.P.
10% Owner
Tango Therapeutics, Inc. (TNGX) 05-Sep-24Private Sale 75,000$11.56$867,135.00(< 1%)
17.0M to 16.93M
29-Aug-24 4:40 PM
View: 
Third Rock Ventures Iv, L.P.
10% Owner
Tango Therapeutics, Inc. (TNGX) 27-Aug-24Private Sale 25,000$11.55$288,665.00(< 1%)
17.2M to 17.18M
20-Aug-24 5:59 PM
View: 
Third Rock Ventures Iv, L.P.
10% Owner
Tango Therapeutics, Inc. (TNGX) 19-Aug-24Market Sale 150,000$10.09$1,513,920.00(< 1%)
17.35M to 17.2M
(1%)
20-Aug-24 5:59 PM
View: 
Third Rock Ventures Iv, L.P.
10% Owner
Tango Therapeutics, Inc. (TNGX) 16-Aug-24Market Sale 135,000$9.79$1,321,450.00(< 1%)
17.49M to 17.35M
(4%)
01-Aug-24 5:51 PM
View: 
Third Rock Ventures Iv, L.P.
10% Owner
Tango Therapeutics, Inc. (TNGX) 01-Aug-24Market Sale 40,000$9.80$392,000.00(< 1%)
17.53M to 17.49M
(4%)
01-Aug-24 5:51 PM
View: 
Third Rock Ventures Iv, L.P.
10% Owner
Tango Therapeutics, Inc. (TNGX) 31-Jul-24Market Sale 100,000$9.93$993,380.00(< 1%)
17.63M to 17.53M
(3%)
01-Aug-24 5:51 PM
View: 
Third Rock Ventures Iv, L.P.
10% Owner
Tango Therapeutics, Inc. (TNGX) 30-Jul-24Market Sale 95,000$9.80$931,114.00(< 1%)
17.72M to 17.63M
(4%)
30-Jul-24 4:15 PM
View: 
Third Rock Ventures Iv, L.P.
10% Owner
Tango Therapeutics, Inc. (TNGX) 26-Jul-24Market Sale 50,000$9.84$491,950.00(< 1%)
17.77M to 17.72M
(4%)
26-Jul-24 4:15 PM
View: 
Third Rock Ventures Iv, L.P.
10% Owner
Tango Therapeutics, Inc. (TNGX) 25-Jul-24Market Sale 100,599$9.87$992,771.00(< 1%)
17.87M to 17.77M
(3%)
26-Jul-24 4:15 PM
View: 
Third Rock Ventures Iv, L.P.
10% Owner
Tango Therapeutics, Inc. (TNGX) 24-Jul-24Market Sale 200,000$9.82$1,963,160.00(1%)
18.07M to 17.87M
(4%)
24-Jul-24 4:15 PM
View: 
Third Rock Ventures Iv, L.P.
10% Owner
Tango Therapeutics, Inc. (TNGX) 23-Jul-24Market Sale 125,000$9.79$1,223,350.00(< 1%)
18.2M to 18.07M
(4%)
24-Jul-24 4:15 PM
View: 
Third Rock Ventures Iv, L.P.
10% Owner
Tango Therapeutics, Inc. (TNGX) 22-Jul-24Market Sale 262,740$9.78$2,570,100.00(1%)
18.46M to 18.2M
(4%)
22-Jul-24 4:15 PM
View: 
Third Rock Ventures Iv, L.P.
10% Owner
Tango Therapeutics, Inc. (TNGX) 18-Jul-24Market Sale 191,490$9.81$1,878,480.00(1%)
18.65M to 18.46M
(4%)
18-Jul-24 4:15 PM
View: 
Third Rock Ventures Iv, L.P.
10% Owner
Tango Therapeutics, Inc. (TNGX) 17-Jul-24Market Sale 550,171$9.79$5,386,340.00(3%)
19.2M to 18.65M
(4%)
02-Jul-24 8:56 PM
View: 
Mva Investors, LLC
Tango Therapeutics, Inc. (TNGX) 02-Jul-24Sale 95,000$8.68$824,600.00(47%)
203.79K to 108.79K
02-Jul-24 8:56 PM
View: 
Mva Investors, LLC
Tango Therapeutics, Inc. (TNGX) 01-Jul-24Sale 110,731$8.87$982,184.00(35%)
314.52K to 203.79K
02-Jul-24 8:56 PM
View: 
Mva Investors, LLC
Tango Therapeutics, Inc. (TNGX) 28-Jun-24Sale 29,000$8.57$248,530.00(8%)
343.52K to 314.52K
07-Jun-24 9:14 PM
View: 
Mva Investors, LLC
Tango Therapeutics, Inc. (TNGX) 07-Jun-24Sale 77,000$6.88$529,760.00(18%)
425.52K to 348.52K
07-Jun-24 9:14 PM
View: 
Mva Investors, LLC
Tango Therapeutics, Inc. (TNGX) 06-Jun-24Sale 63,000$7.24$456,120.00(13%)
488.52K to 425.52K
07-Jun-24 5:13 PM
View: 
Ketchum John B
Director
Tango Therapeutics, Inc. (TNGX) 05-Jun-24Grant 4,687----47%
10.0K to 14.69K
07-Jun-24 5:17 PM
View: 
Rothenberg MacE
Director
Tango Therapeutics, Inc. (TNGX) 05-Jun-24Grant 6,250----125%
5.0K to 11.25K
07-Jun-24 5:21 PM
View: 
Peters Malte
Director
Tango Therapeutics, Inc. (TNGX) 05-Jun-24Grant 6,250----125%
5.0K to 11.25K
07-Jun-24 5:11 PM
View: 
Borisy Alexis
Director
Tango Therapeutics, Inc. (TNGX) 05-Jun-24Grant 6,250----125%
5.0K to 11.25K
07-Jun-24 5:16 PM
View: 
Calhoun Lesley Ann
Director
Tango Therapeutics, Inc. (TNGX) 05-Jun-24Sale (Planned) 5,000$7.21$36,039.00400%
1.25K to 6.25K
03-May-24 9:34 PM
View: 
Mva Investors, LLC
Tango Therapeutics, Inc. (TNGX) 03-May-24Sale 60,000$7.61$456,600.00(11%)
548.52K to 488.52K
03-May-24 9:34 PM
View: 
Mva Investors, LLC
Tango Therapeutics, Inc. (TNGX) 02-May-24Sale 75,000$7.56$567,000.00(12%)
623.52K to 548.52K
03-May-24 9:34 PM
View: 
Mva Investors, LLC
Tango Therapeutics, Inc. (TNGX) 01-May-24Sale 75,000$7.43$557,250.00(11%)
698.52K to 623.52K
21-Feb-24 5:52 PM
View: 
Third Rock Ventures Iv, L.P.
10% Owner
Tango Therapeutics, Inc. (TNGX) 20-Feb-24Private Sale 162,500$12.00$1,950,000.00(< 1%)
19.36M to 19.2M
08-Feb-24 9:08 PM
View: 
Beckman Daniella
Chief Financial Officer
Tango Therapeutics, Inc. (TNGX) 07-Feb-24Sale 1,817$12.62$22,930.20(1%)
134.21K to 132.4K
08-Feb-24 9:04 PM
View: 
Crystal Adam
See Remarks
Tango Therapeutics, Inc. (TNGX) 07-Feb-24Sale 4,083$12.62$51,526.60(3%)
123.56K to 119.48K
08-Feb-24 9:09 PM
View: 
Barry Douglas
General Counsel
Tango Therapeutics, Inc. (TNGX) 07-Feb-24Sale 1,354$12.62$17,087.20(3%)
45.34K to 43.98K
08-Feb-24 9:14 PM
View: 
Weber Barbara
Chief Executive Officer
Director
Tango Therapeutics, Inc. (TNGX) 07-Feb-24Sale 4,457$12.62$56,246.40(< 1%)
1.54M to 1.54M
08-Feb-24 9:14 PM
View: 
Weber Barbara
Chief Executive Officer
Director
Tango Therapeutics, Inc. (TNGX) 06-Feb-24Private Sale 4,681$12.56$58,805.50(< 1%)
1.54M to 1.54M
08-Feb-24 9:08 PM
View: 
Beckman Daniella
Chief Financial Officer
Tango Therapeutics, Inc. (TNGX) 06-Feb-24Private Sale 1,908$12.56$23,969.40(1%)
136.12K to 134.21K
08-Feb-24 9:04 PM
View: 
Crystal Adam
See Remarks
Tango Therapeutics, Inc. (TNGX) 06-Feb-24Private Sale 4,288$12.56$53,868.40(3%)
127.85K to 123.56K
08-Feb-24 9:09 PM
View: 
Barry Douglas
General Counsel
Tango Therapeutics, Inc. (TNGX) 06-Feb-24Private Sale 1,422$12.56$17,864.00(3%)
46.76K to 45.34K
05-Feb-24 4:21 PM
View: 
Weber Barbara
Chief Executive Officer
Director
Tango Therapeutics, Inc. (TNGX) 01-Feb-24Grant 87,168----100%
0 to 87.17K
05-Feb-24 4:22 PM
View: 
Crystal Adam
See Remarks
Tango Therapeutics, Inc. (TNGX) 01-Feb-24Grant 46,599----100%
0 to 46.6K
05-Feb-24 4:27 PM
View: 
Beckman Daniella
Chief Financial Officer
Tango Therapeutics, Inc. (TNGX) 01-Feb-24Grant 39,413----100%
0 to 39.41K
05-Feb-24 4:19 PM
View: 
Barry Douglas
General Counsel
Tango Therapeutics, Inc. (TNGX) 01-Feb-24Grant 22,859----100%
0 to 22.86K
02-Nov-23 4:49 PM
View: 
Crystal Adam
See Remarks
Tango Therapeutics, Inc. (TNGX) 01-Nov-23Sale 7,507$8.39$62,994.20(8%)
88.76K to 81.25K
17-Oct-23 6:04 PM
View: 
Boxer Capital, LLC
Tango Therapeutics, Inc. (TNGX) 16-Oct-23Purchase 500,000$6.84$3,420,000.003%
15.41M to 15.91M
17-Oct-23 6:04 PM
View: 
Boxer Capital, LLC
Tango Therapeutics, Inc. (TNGX) 13-Oct-23Private Purchase 750,000$7.07$5,302,500.005%
14.66M to 15.41M
11-Oct-23 9:22 PM
View: 
Boxer Capital, LLC
Tango Therapeutics, Inc. (TNGX) 09-Oct-23Market Sale 50,000$9.91$495,500.00(< 1%)
14.89M to 14.84M
(3%)
11-Oct-23 9:22 PM
View: 
Boxer Capital, LLC
Tango Therapeutics, Inc. (TNGX) 09-Oct-23Market Sale 175,000$9.97$1,744,750.00(1%)
14.84M to 14.66M
(2%)
31-Aug-23 4:07 PM
View: 
Ketchum John B
Director
Tango Therapeutics, Inc. (TNGX) 29-Aug-23Grant 10,000----100%
0 to 10.0K
15-Aug-23 9:34 PM
View: 
Boxer Capital, LLC
Director
Tango Therapeutics, Inc. (TNGX) 11-Aug-23Private Purchase 475,000$5.15$2,446,250.003%
14.41M to 14.89M